Literature DB >> 18166672

Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particles and LC-MALDI-TOF-MS.

Jochen F Peter1, Angela M Otto, Bernhard Wolf.   

Abstract

Tumor cells change their genetic expression pattern as they progress to states of increasing malignancy. Investigations at the DNA and RNA level alone cannot provide all the information resulting after the translation and processing of the corresponding proteins, which is one reason for a poor correlation between mRNA and the respective protein abundance. In diagnostics, differentially expressed peptides or proteins are important markers for the early detection of cancer. Unfortunately, tumor cells secrete peptides and proteins in only very low amounts, making mass spectrometric determination very difficult. In this publication, methods have been developed for the effective enrichment and cleanup of substances secreted by cultivated cancer cells. To obviate peptides from fetal calf serum used in cell culture, a serum surrogate was developed, which maintained growth of the cancer cells. After the binding of substances from cell-culture supernatants to custom-made magnetic reversed-phase particles, the substances were eluted and separated by capillary high-performance liquid chromatography. Fractions were spotted directly on a MALDI target, and MALDI-TOF mass spectrometric data acquisition was performed in automatic mode. This technology was used to detect substances secreted by two mammary carcinoma cell lines differing in their malignancy (MCF-7, MDA-MB 231). Unequivocal differences in the peptide secretion patterns were observed. In conclusion, this system allows the sensitive investigation of peptides secreted by cancer cells in culture and provides a valuable tool for the investigation of cancer cells in different states of malignancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18166672      PMCID: PMC2392993     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  29 in total

1.  A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes.

Authors:  Irina Kratchmarova; Dario E Kalume; Blagoy Blagoev; Philipp E Scherer; Alexandre V Podtelejnikov; Henrik Molina; Perry E Bickel; Jens S Andersen; Minerva M Fernandez; Jacob Bunkenborg; Peter Roepstorff; Karsten Kristiansen; Harvey F Lodish; Matthias Mann; Akhilesh Pandey
Journal:  Mol Cell Proteomics       Date:  2002-03       Impact factor: 5.911

2.  A method for the selective isolation and enrichment of carrier protein-bound low-molecular weight proteins and peptides in the blood.

Authors:  Serena Camerini; Maria Letizia Polci; Lance A Liotta; Emanuel F Petricoin; Weidong Zhou
Journal:  Proteomics Clin Appl       Date:  2007-01-22       Impact factor: 3.494

3.  Profiling of amyloid beta peptide variants using SELDI Protein Chip arrays.

Authors:  H Davies; L Lomas; B Austen
Journal:  Biotechniques       Date:  1999-12       Impact factor: 1.993

4.  Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry.

Authors:  Mirre E de Noo; Rob A E M Tollenaar; Aliye Ozalp; Peter J K Kuppen; Marco R Bladergroen; Paul H C Eilers; André M Deelder
Journal:  Anal Chem       Date:  2005-11-15       Impact factor: 6.986

5.  Mass spectrometric study of the effects of hydrophobic surface chemistry and morphology on the digestion of surface-bound proteins.

Authors:  Alan Doucette; David Craft; Liang Li
Journal:  J Am Soc Mass Spectrom       Date:  2003-03       Impact factor: 3.109

6.  Effect of medium composition on protein degradation and DNA synthesis in rat embryo fibroblasts.

Authors:  M J Warburton; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

7.  Mass spectrometric high-throughput analysis of serum-free conditioned medium from cancer cell lines.

Authors:  K Sato; K Sasaki; Y Akiyama; K Yamaguchi
Journal:  Cancer Lett       Date:  2001-09-20       Impact factor: 8.679

8.  Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid.

Authors:  Hannah Alexander; Andrew L Stegner; Colette Wagner-Mann; Garrett C Du Bois; Stephen Alexander; Edward R Sauter
Journal:  Clin Cancer Res       Date:  2004-11-15       Impact factor: 12.531

9.  Chemotherapeutic drugs change actin skeleton organization and the expression of beta-thymosins in human breast cancer cells.

Authors:  A M Otto; C S G Müller; T Huff; E Hannappel
Journal:  J Cancer Res Clin Oncol       Date:  2002-03-19       Impact factor: 4.553

10.  Discordant protein and mRNA expression in lung adenocarcinomas.

Authors:  Guoan Chen; Tarek G Gharib; Chiang-Ching Huang; Jeremy M G Taylor; David E Misek; Sharon L R Kardia; Thomas J Giordano; Mark D Iannettoni; Mark B Orringer; Samir M Hanash; David G Beer
Journal:  Mol Cell Proteomics       Date:  2002-04       Impact factor: 5.911

View more
  3 in total

1.  Pattern-based diagnosis and screening of differentially expressed serum proteins for rheumatoid arthritis by proteomic fingerprinting.

Authors:  Li Long; Ru Li; Yongzhe Li; Chaojun Hu; Zhanguo Li
Journal:  Rheumatol Int       Date:  2010-03-25       Impact factor: 2.631

2.  Establishment of a novel diagnostic model for Sjögren's syndrome by proteomic fingerprinting.

Authors:  Yuhui Li; Xiaolin Sun; Xuewu Zhang; Yuqin Yang; Rulin Jia; Xu Liu; Ru Li; Yanying Liu; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2014-09-02       Impact factor: 2.980

Review 3.  Sample preparation techniques for the untargeted LC-MS-based discovery of peptides in complex biological matrices.

Authors:  Inez Finoulst; Martijn Pinkse; William Van Dongen; Peter Verhaert
Journal:  J Biomed Biotechnol       Date:  2011-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.